Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Hordinsky

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Drugs in Dermatology : JDD|March 6, 2023
Utilization Management Barriers Among Patients With Cicatricial AlopeciaKatelyn Rypka, James Pathoulas, Kris Wharton, et al.
Journal of the American Academy of Dermatology|December 1, 2025
Red islands: A novel trichoscopic sign in fibrosing alopecia in a pattern distributionMaria Fernanda Reis Gavazzoni Dias, Nadia El Kadi, Suleima Arruda, et al.
Journal of the American Academy of Dermatology|August 3, 2019
Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysisAmrita Goyal, Daniel O'Leary, Kavita Goyal, et al.
Journal of the American Academy of Dermatology|June 26, 2019
Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort studyAmrita Goyal, Daniel O'Leary, Kavita Goyal, et al.
The Journal of Investigative Dermatology|July 20, 2007
Human leukocyte antigen class II alleles are associated with risk of alopecia areataNazila Barahmani, Mariza de Andrade, Joshua P Slusser, et al.
Archives of Dermatology|November 18, 2009
Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled studyBruce E Strober, Kavita Menon, Amy McMichael, et al.
Ebiomedicine|June 21, 2016
Molecular signatures define alopecia areata subtypes and transcriptional biomarkersAli Jabbari, Jane E Cerise, James C Chen, et al.
Journal of the American Academy of Dermatology|December 22, 2024
A single-center retrospective cohort study of hydroxychloroquine-related adverse events in adults with lymphocytic cicatricial alopeciaKatelyn J Rypka, Zachary Wendland, Hannah Schull, et al.
Journal of the American Academy of Dermatology|November 13, 2017
Objective outcome measures: Collecting meaningful data on alopecia areataElise A Olsen, Janet Roberts, Leonard Sperling, et al.
Pediatric Dermatology|July 17, 2023
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trialMaria Hordinsky, Adelaide A Hebert, Melinda Gooderham, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Drugs in Dermatology : JDD|March 6, 2023
Utilization Management Barriers Among Patients With Cicatricial AlopeciaKatelyn Rypka, James Pathoulas, Kris Wharton, et al.
Journal of the American Academy of Dermatology|December 1, 2025
Red islands: A novel trichoscopic sign in fibrosing alopecia in a pattern distributionMaria Fernanda Reis Gavazzoni Dias, Nadia El Kadi, Suleima Arruda, et al.
Journal of the American Academy of Dermatology|August 3, 2019
Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysisAmrita Goyal, Daniel O'Leary, Kavita Goyal, et al.
Journal of the American Academy of Dermatology|June 26, 2019
Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort studyAmrita Goyal, Daniel O'Leary, Kavita Goyal, et al.
The Journal of Investigative Dermatology|July 20, 2007
Human leukocyte antigen class II alleles are associated with risk of alopecia areataNazila Barahmani, Mariza de Andrade, Joshua P Slusser, et al.
Archives of Dermatology|November 18, 2009
Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled studyBruce E Strober, Kavita Menon, Amy McMichael, et al.
Ebiomedicine|June 21, 2016
Molecular signatures define alopecia areata subtypes and transcriptional biomarkersAli Jabbari, Jane E Cerise, James C Chen, et al.
Journal of the American Academy of Dermatology|December 22, 2024
A single-center retrospective cohort study of hydroxychloroquine-related adverse events in adults with lymphocytic cicatricial alopeciaKatelyn J Rypka, Zachary Wendland, Hannah Schull, et al.
Journal of the American Academy of Dermatology|November 13, 2017
Objective outcome measures: Collecting meaningful data on alopecia areataElise A Olsen, Janet Roberts, Leonard Sperling, et al.
Pediatric Dermatology|July 17, 2023
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trialMaria Hordinsky, Adelaide A Hebert, Melinda Gooderham, et al.
Pageof 8